Hefei Lifeon Pharmaceutical Co Ltd (003020)

Currency in CNY
35.90
-2.60(-6.75%)
Closed·
003020 Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Earnings results expected today
003020 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
35.9040.00
52 wk Range
16.4041.47
Key Statistics
Bid/Ask
35.90 / 35.90
Prev. Close
38.5
Open
37.34
Day's Range
35.9-40
52 wk Range
16.4-41.47
Volume
17.56M
Average Volume (3m)
9.04M
1-Year Change
114.81%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
003020 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Cash flows can sufficiently cover interest payments

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Hefei Lifeon Pharmaceutical Co Ltd Company Profile

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients. It operates through Pharmaceutical Industry, Pharmaceutical Wholesale and Distribution, and Pharmaceutical Retail Business segments. The company offers active pharmaceutical ingredients, which include nifedipine, paliperidone, prilocaine, methylphenidate hydrochloride, dimercaptosuccinic acid, doxazosin mesylate, paeonol, urea, felodipine, and troxerutin; and medical preparations, such as osmotic pump preparations, central nervous systems, Chinese patent medicines, eye drops, external use, and general oral medicines. In addition, it provides medical intermediates, including 3-methoxy-1 propanethiol, mercaptosuccinic acid, domiphene, sodium dimercaptosulfonate, 3-mercapto-1-propanol, paeonol, sodium paeonol sulfonate, methyl 2,3-dichlorobenzylidene acetoacetate, n-[(1,4-benzodioxan-2-yl) carbonyl piperazine hydrochloride, alogliptin benzoate, roflumilast, and zofenopril calcium; plant extract products, such as clove oil and campanula extracts; and pieces that consist of poria decoction, astragalus, honeysuckle, rose, and phellinus decoction. Further, the company offers central nervous system drugs, cardiovascular drugs, digestive system drugs, ophthalmic drugs, external skin drugs and other fields. Hefei Lifeon Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Hefei, China.

Employees
1456
Market
China

Compare 003020 to Peers and Sector

Metrics to compare
003020
Peers
Sector
Relationship
P/E Ratio
40.5x32.1x−0.6x
PEG Ratio
−3.64−0.430.00
Price/Book
3.8x3.1x2.6x
Price / LTM Sales
4.4x4.8x3.3x
Upside (Analyst Target)
-16.2%39.0%
Fair Value Upside
Unlock2.4%4.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.88%
Dividend Yield
1.39%
Industry Median 1.43%
Annualised payout
0.50
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.20 / --
Revenue / Forecast
360.23M / --
EPS Revisions
Last 90 days

003020 Income Statement

FAQ

What Stock Exchange Does Hefei Lifeon Trade On?

Hefei Lifeon is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Hefei Lifeon?

The stock symbol for Hefei Lifeon is "003020."

What Is the Hefei Lifeon Market Cap?

As of today, Hefei Lifeon market cap is 5.92B.

What Is Hefei Lifeon's Earnings Per Share (TTM)?

The Hefei Lifeon EPS (TTM) is 0.88.

When Is the Next Hefei Lifeon Earnings Date?

Hefei Lifeon will release its next earnings report on 25 Aug 2025.

From a Technical Analysis Perspective, Is 003020 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Hefei Lifeon Stock Split?

Hefei Lifeon has split 3 times.

How Many Employees Does Hefei Lifeon Have?

Hefei Lifeon has 1456 employees.

What is the current trading status of Hefei Lifeon (003020)?

As of 26 Aug 2025, Hefei Lifeon (003020) is trading at a price of 35.90, with a previous close of 38.50. The stock has fluctuated within a day range of 35.90 to 40.00, while its 52-week range spans from 16.40 to 41.47.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.